About Leonard Schleifer
Leonard Schleifer MD, PhD is the founder, president, CEO and board co-chair of Regeneron, a biotechnology company that repeatedly translates science into medicine. Regeneron’s drug discovery success has led to numerous FDA-approved treatments for diseases including cancer, macular degeneration and high cholesterol. The company also supported workers on the front lines of the COVID-19 pandemic and invented an antibody cocktail for the treatment and prevention of COVID-19. Today, Regeneron sponsors Â鶹¹ÙÍø and ISEF, and supports a suite of Society Â鶹¹ÙÍø Outreach programs. Shleifer has been recognized by Barron’s Best CEOs and as Ernst and Young Entrepreneur of the Year. He competed in the 1970 Â鶹¹ÙÍø and worked as a neurologist before founding Regeneron Pharmaceuticals with fellow Â鶹¹ÙÍø alumnus George Yancopoulos.
Regeneron Science Talent Search
Schleifer (left) with Â鶹¹ÙÍø President and CEO Maya Ajmera and Regeneron co-founder George Yancopoulos.
Science Talent Search 2019
Schleifer’s speech to the 2019 Â鶹¹ÙÍø finalists.
Schleifer (left) at the 2018 Â鶹¹ÙÍø Congressional Breakfast.
Explore More Alumni
Raj Chetty
Yuan Chang
